Abstract:Purpose: Monitoring tumor response during the course of treatment and adaptively modifying treatment plan based on tumor biological feedback may represent a new paradigm for radiotherapy. Diffusion MRI has shown great promises in assessing and predicting tumor response to radiotherapy. However, the conventional diffusion-weighted single-shot echo-planar-imaging (DW-ssEPI) technique suffers from limited resolution, severe distortion, and possibly inaccurate ADC at low field strength. The purpose of this work was to develop a reliable, accurate and distortion-free diffusion MRI technique that is practicable for longitudinal tumor response evaluation and adaptive radiotherapy on a 0.35 T MRI-guided radiotherapy system. Methods: A diffusion-prepared turbo spin echo readout (DP-TSE) sequence was developed and compared with the conventional diffusion-weighted single-shot echo-planar-imaging sequence on a 0.35 T MRI-guided radiotherapy system (ViewRay). A spatial integrity phantom was used to quantitate and compare the geometric accuracy of the two diffusion sequences for three orthogonal orientations. The apparent diffusion coefficient (ADC) accuracy was evaluated on a diffusion phantom under both 0 degrees C and room temperature to cover a diffusivity range between 0.40 x 10(-3) and 2.10 x 10(-3) mm(2)/s. Ten room temperature measurements repeated on five different days were conducted to assess the ADC reproducibility of DP-TSE. Two glioblastoma (GBM) and six sarcoma patients were included to examine the in vivo feasibility. The target registration error (TRE) was calculated to quantitate the geometric accuracy where structural CT or MR images were co-registered to the diffusion images as references. ADC maps from DP-TSE and DW-ssEPI were calculated and compared. A tube phantom was placed next to patients not treated on ViewRay, and ADCs of this reference tube were also compared. Results: The proposed DP-TSE passed the spatial integrity test (< 1 mm within 100 mm radius and < 2 mm within 175 mm radius) under the three orthogonal orientations. The detected errors were 0.474 0.355 mm, 0.475 +/- 0.287 mm, and 0.546 +/- 0.336 mm in the axial, coronal, and sagittal plane. DW-ssEPI, however, failed the tests due to severe distortion and low signal intensity. Noise correction must be performed for the DW-ssEPI to avoid ADC quantitation errors, whereas it is optional for DP-TSE. At 0 degrees C, the two sequences provided accurate quantitation with < 3% variation with the reference. In the room temperature study, discrepancies between ADCs from DP-TSE and the reference were within 4%, but could be as high as 8% for DW-ssEPI after the noise correction. Excellent ADC reproducibility with a coefficient of variation < 5% was observed among the 10 measurements of DP-TSE, indicating desirable robustness for ADC-based tumor response assessment. In vivo TRE in DP-TSE was less than 1.6 mm overall, whereas it could be greater than 12 mm in DW-ssEPI. For GBM patients, the CSF and brain tissue ADCs from DP-TSE were within the ranges found in literature. ADC differences between the two techniques were within 8% among the six sarcoma patients. For the reference tube that had a relatively low diffusivity, the two diffusion sequences provided matched measurements. Conclusion: A diffusion technique with excellent geometric fidelity, accurate, and reproducible ADC measurement was demonstrated for longitudinal tumor response assessment using a low-field MRI-guided radiotherapy system. (C) 2017 American Association of Physicists in Medicine

Quantification of Gd-Dtpa Concentration in Neuroimaging Using T-1 3d Mp-Rage Sequence at 3.0 T

Quantification of Gd-DTPA concentration in neuroimaging using T₁3D MP-RAGE sequence at 3.0 T.

3D Isotropic Resolution Diffusion-Prepared Magnitude-Stabilized Bssfp Imaging with High Geometric Fidelity at 1.5 Tesla

Three-dimensional Simultaneous Brain Mapping of T1, T2, T2*and Magnetic Susceptibility with MR Multitasking

Three-dimensional simultaneous brain T 1 , T 2 , and ADC mapping with MR Multitasking.

Nmr Studies of Gd(Dtpa-Bin) in Human Serum Albumin Solution

Distortion-Free Diffusion MRI using an MRI-Guided Tri-Cobalt 60 Radiotherapy System: Sequence Verification and Preliminary Clinical Experience.

Three-dimensional simultaneous brain T<sub>1</sub>, T<sub>2</sub>, and ADC mapping with MR Multitasking

The Development of Dendritic Gd-Dtpa Complexes for Mri Contrast Agents

Quantitative brain T1 maps derived from T1-weighted MRI acquisitions: a proof-of-concept study

[Imaging and Quantitative Measurement of Brain Extracellular Space Using MRI Gd-DTPA Tracer Method].

In Vivo Quantitative Measurement of Diffusion Parameters in Brain Extracellular Space of Rat by Using Magnetic Resonance Imaging

Low-dose Contrast-Enhanced Magnetic Resonance Imaging of Brain Metastases at 3.0 T Using High-Relaxivity Contrast Agents.

3D MR fingerprinting for dynamic contrast‐enhanced imaging of whole mouse brain

3D MR Fingerprinting for Dynamic Contrast-Enhanced Imaging of Whole Mouse Brain

Verification of Quantification of Quantitative Susceptibility Mapping for Estimating the Amount of Gadolinium Deposited in the Brain: a Preliminary Phantom Study

Effect Of Intravenous Gadolinium-Dtpa On Diffusion-Weighted Imaging For Prostate Lesions And Normal Tissue At 3.0-Tesla Magnetic Resonance Imaging

Optimization of Contrast Agent Dosage on Contrast-Enhanced T2 Fluid-Attenuated Inversion Recovery: an in Vitro and in Vivo Study

Intra-Individual Comparison of Different Gadolinium-Based Contrast Agents in the Quantitative Evaluation of C6 Glioma with Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semi-solid magnetization transfer reference (EMR) signals: Application to a rat glioma model at 4.7 tesla.

A dual-targeted Gd-based contrast agent for magnetic resonance imaging in tumor diagnosis